HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B*5701 subjects.

Abstract
HLA-B*5701 is the host factor most strongly associated with slow HIV-1 disease progression, although rates can vary within this group. Underlying mechanisms are not fully understood but likely involve both immunological and virological dynamics. The present study investigated HIV-1 in vivo evolution and epitope-specific CD8(+) T cell responses in six HLA-B*5701 patients who had not received antiretroviral treatment, monitored from early infection for up to 7 years. The subjects were classified as high-risk progressors (HRPs) or low-risk progressors (LRPs) based on baseline CD4(+) T cell counts. Dynamics of HIV-1 Gag p24 evolution and multifunctional CD8(+) T cell responses were evaluated by high-resolution phylogenetic analysis and polychromatic flow cytometry, respectively. In all subjects, substitutions occurred more frequently in flanking regions than in HLA-B*5701-restricted epitopes. In LRPs, p24 sequence diversity was significantly lower; sequences exhibited a higher degree of homoplasy and more constrained mutational patterns than HRPs. The HIV-1 intrahost evolutionary rate was also lower in LRPs and followed a strict molecular clock, suggesting neutral genetic drift rather than positive selection. Additionally, polyfunctional CD8(+) T cell responses, particularly to TW10 and QW9 epitopes, were more robust in LRPs, who also showed significantly higher interleukin-2 (IL-2) production in early infection. Overall, the findings indicate that HLA-B*5701 patients with higher CD4 counts at baseline have a lower risk of HIV-1 disease progression because of the interplay between specific HLA-linked immune responses and the rate and mode of viral evolution. The study highlights the power of a multidisciplinary approach, integrating high-resolution evolutionary and immunological data, to understand mechanisms underlying HIV-1 pathogenesis.
AuthorsMelissa M Norström, Marcus Buggert, Johanna Tauriainen, Wendy Hartogensis, Mattia C Prosperi, Mark A Wallet, Frederick M Hecht, Marco Salemi, Annika C Karlsson
JournalJournal of virology (J Virol) Vol. 86 Issue 18 Pg. 9802-16 (Sep 2012) ISSN: 1098-5514 [Electronic] United States
PMID22761389 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • HIV Core Protein p24
  • HLA-B Antigens
  • HLA-B*57:01 antigen
Topics
  • CD4 Lymphocyte Count
  • CD8-Positive T-Lymphocytes (immunology, virology)
  • Disease Progression
  • Evolution, Molecular
  • HIV Core Protein p24 (genetics)
  • HIV Infections (genetics, immunology, virology)
  • HIV-1 (genetics, immunology)
  • HLA-B Antigens (genetics)
  • Host-Pathogen Interactions (genetics, immunology)
  • Humans
  • Likelihood Functions
  • Longitudinal Studies
  • Male
  • Molecular Sequence Data
  • Phylogeny
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: